Members Only Content

Subscribe to get full access

Free Preview

Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in with Maxx Chatsko on his new quest to build accurate, risk-adjusted net present value (rNPV) models for drug developers.

related news & insights

  • January 10, 2025||0 min||||

    Coupang Deep Dive: January 2025

    CPNG Recommendation Jan 2025

  • an image of a man handing out hundred dollar bills
    January 7, 2025||0.2 min||||

    Dividend Hunting Season is Open

    If you love dividends, now's a good time to go hunting. Several companies -- some well known, others not -- [...]

  • January 9, 2025||1.3 min||||

    How to Update Your 7investing Preferred Payment Method

    Did you just get a new credit card or did your existing one expire? If so, this article is for [...]